ClinConnect ClinConnect Logo
Search / Trial NCT06321146

Evaluation of EEG Power Spectrum in Patients With Traumatic Coma

Launched by RENJI HOSPITAL · Mar 17, 2024

Trial Information

Current as of July 23, 2025

Not yet recruiting

Keywords

Coma Traumatic Brain Injury Eeg Power Spectrum

ClinConnect Summary

This clinical trial is studying how brain activity, measured by a technique called EEG (electroencephalogram), can help doctors understand the chances of recovery for patients in a coma due to severe brain injuries. The goal is to find a reliable and easy way to assess levels of consciousness in these patients over time. By looking at patterns in the brain’s electrical activity, researchers hope to gain valuable insights into how and when a patient might regain awareness.

To participate in this study, individuals must be at least 18 years old and have been in a coma for more than 28 days because of a closed traumatic brain injury. They need to have a legal representative who can provide consent for them to join. However, patients with unstable vital signs, a history of severe mental illnesses, uncontrolled epilepsy, or who are pregnant cannot participate. The study is still in the planning phase and has not yet started recruiting participants, but it holds the promise of improving how doctors can predict recovery outcomes for patients in similar situations.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Coma over 28 days due to closed traumatic brain injury
  • Age above 18 years old
  • Consented by legal representative
  • Exclusion Criteria:
  • Unstable vital signs
  • History of mental disorder or neurodegenerative diseases
  • Uncontrolled epilepsy
  • Unable to record scalp EEG
  • Pregnancy

About Renji Hospital

Renji Hospital, a prestigious medical institution affiliated with Shanghai Jiao Tong University School of Medicine, is dedicated to advancing healthcare through innovative clinical research. With a strong emphasis on patient-centered care, Renji Hospital conducts a wide range of clinical trials across various therapeutic areas, harnessing cutting-edge technology and evidence-based practices. The hospital's multidisciplinary team of experienced researchers and medical professionals collaborates closely to ensure rigorous study design and execution, aiming to contribute significantly to medical knowledge and improve treatment outcomes for patients worldwide.

Locations

Changsha, Hunan, China

Beijing, Beijing, China

Shanghai, Shanghai, China

Hefei, Anhui, China

Nanjing, Jiangsu, China

Patients applied

0 patients applied

Trial Officials

Junfeng Feng, Dr.

Study Director

Renji Hospital, School of Medicine, Shanghai Jiaotong University

Guoyi Gao, Dr.

Study Director

Beijing Tiantan Hospital

Jinfang Liu, Dr.

Study Director

Xiangya Hospital of Central South University

Chiyuan Ma, Dr.

Study Director

The General Hospital of Eastern Theater Command

Yongming Zhang, Dr.

Study Director

Anhui No.2 Provincial People's Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported